GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study

ABSTRACT Objective In general practice settings, the weight‐loss effectiveness of glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs) is often lower than in clinical efficacy trials. Little is known about whether this may be due, in part, to clinicians' knowledge about obesity medicine and the nat...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Dina H. Griauzde, Cassie D. Turner, Amal Othman, Lauren Oshman, Jonathan Gabison, Patricia K. Arizaca‐Dileo, James Henderson, Deena Beckius, Joyce M. Lee, Shelley Stoll, Kathryn Herrera‐Theut, Caroline R. Richardson, Jeffrey T. Kullgren, Gretchen A. Piatt, Michele Heisler, Andrew Kraftson
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wiley 2026-04-01
Serier:	Obesity Science & Practice
Fag:	anti‐obesity medications GLP‐1 RAs obesity primary care
Online adgang:	https://doi.org/10.1002/osp4.70136
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!